Michael R. Liebowitz, M.D.
Managing Director and Founder
Dr. Liebowitz has been a pioneer in Social Anxiety Disorder and is an internationally recognized leader in the research of anxiety and affective disorders. He is Board Certified in Psychiatry and Neurology, and has devoted over thirty years to the research and treatment of anxiety, phobic, and affective disorders, serving as chair of the DSM-IV Workgroup in Anxiety Disorders. His major contributions have been in the areas of social anxiety, obsessive-compulsive disorder, panic disorder, atypical depression, and rapid cycling mood disorders. Dr. Liebowitz is also a consultant to many major pharmaceutical companies for clinical trial design.
In 2007, Dr. Liebowitz retired from his position as Director of the Anxiety Disorders Clinic at the New York State Psychiatric Institute, a post he held since 1982. During his tenure, his influential research led to the recognition of Social Anxiety Disorder (SAD) as a prevalent, debilitating, and chronic condition. He also developed the Liebowitz Social Anxiety Scale (LSAS), which is now widely utilized as a primary outcome measure for clinical trials of SAD. He has been at the forefront of psychopharmacology studies in generalized SAD. Dr. Liebowitz continues as Professor of Clinical Psychiatry at Columbia University. He is currently involved in the development and testing of rapidly acting anxiolytic medications. Dr. Liebowitz' dedication to MRN ensures clinical trial excellence in all studies we undertake.
Kyra Blatt, M.D.
Senior Research Neurologist
Dr. Blatt joined MRN in February 2006. She completed her residency in Neurology at the Albert Einstein College of Medicine and has been involved in clinical research since her fellowship in Movement Disorders at Beth Israel Medical Center in 2000. Dr. Blatt is Board Certified in Neurology and is subspecialty-trained in Dementia and Movement Disorders, as well as in peripheral nerve disorders and electrophysiology. In 2002, she studied Sleep Medicine at Wake Forest Hospital in North Carolina.
Dr. Blatt has published peer-reviewed articles on movement disorders and has co-authored a chapter in J. Noteworthy’s Neurological Therapeutics about the treatment and diagnosis of Generalized Torsion Dystonia. She has specialized training in the field of Botox for both neurologic disorders as well as for the treatment of conditions such as low back and cervical pain.
Dr. Blatt has been instrumental in leading the growth of MRN's Neurology and Chronic Pain Division, which offers studies including novel compounds and delivery methods for the treatment of chronic pain conditions, neuropathies, and arthritis.
Contact Dr. Blatt by email at: KBlatt@MedicalResearchNetwork.com
Jason Careri, M.D.
Dr. Careri joined MRN in February 2013. He completed his residency in Psychiatry at Albert Einstein College of Medicine and is a former Assistant Professor at Mt. Sinai School of Medicine. He is Board Certified in Psychiatry and Neurology and has been involved in clinical and basic science research since 1997.
Dr. Careri has published peer-reviewed articles and given conference presentations on anxiety disorders and addiction. In addition, he operates a private practice in Garden City, NY specializing in the treatment of anxiety and mood disorders.
Contact Dr. Careri by email at: JCareri@MedicalResearchNetwork.com
Ann E. Draine
Ann has been with MRN since 2004, when she was initially hired as a Clinical Research Coordinator. In 2006, she was promoted to the post of Research Administrator and in 2011 to Associate Director. She manages MRN's clinical trial contracts and fiscal budget and provides daily oversight of clinic staff and coordination of clinical activities, ensuring consistent adherence to study protocols, Good Clinical Practices, FDA guidelines, and site SOPs. Ann oversees the regulatory affairs and documentation at MRN, as well as serving as our experienced recruitment specialist.
Ann obtained her Bachelor of Arts degrees in Psychology and Spanish from Dickinson College and is fluent in Spanish. She has co-published three posters which have been presented at NCDEU and APA meetings, and has co-authored an article published in the Journal of Affective Disorders.
Ann is trained and certified in the administration of many standardized clinical ratings for mood and affective disorders. She has been certified to perform Painful and Swollen Joint Assessments, Quantitative Sensory Testing, and standardized cognitive exams. Ann is also IATA certified and is trained and skilled in the preparation of study medication for intravenous injections.
Contact Ann by email at: ADraine@MedicalResearchNetwork.com
Clinical Research Coordinator
Junko has been with MRN since October 2015, during which time she has contributed to the coordination, organization, and success of over 15 different research studies. She has experience with a variety of clinical indications, including Major Depressive Disorder, treatment-resistant Major Depression, ADHD, Social Anxiety Disorder, Opioid Addiction, Mild Cognitive Impairment, Low Back Pain, and Osteoarthritis. She has worked in Phase II, III, and IV studies involving compounds administered orally, intravenously, and topically. Junko is trained and certified in GCP, risk assessment, and phlebotomy.
Junko holds a Master of Arts in Psychology in Education from the Teachers College at Columbia University, as well as a Bachelor of Arts in Liberal Arts from Soka University of America. She currently contributes to research at Columbia University's Mailman School of Public Health with Dr. Lawrence Yang, and before that worked as a Research Assistant at Columbia's Department of Psychiatry and NYSPI.
Contact Junko by email at: JMorita@MedicalResearchNetwork.com
Clinical Research Coordinator
Matt has been with MRN since October 2015, during which time he has contributed to the coordination, organization, and success of over 15 different research studies. He has experience with a variety of clinical indications, including Opioid Addiction, Major Depressive Disorder, treatment-resistant Major Depression, ADHD, Social Anxiety Disorder, Mild Cognitive Impairment, Postherpetic Neuralgia, Low Back Pain, and Osteoarthritis. He has worked in Phase II, III, and IV studies involving compounds administered orally, intravenously, and topically. Matt is trained and certified in GCP.
Matt holds a Bachelor of Arts in Communications from Marymount Manhattan College, with a minor in Business Administration. Prior to joining MRN, he worked in recruitment, marketing, publicity, and video production, experience which makes him invaluable as a Subject Recruitment Specialist for clinical trials here at MRN.
Contact Matt by email at: MTurzilli@MedicalResearchNetwork.com
Clinical Research Coordinator
Melissa has been with MRN since February 2016, during which time she has contributed to the coordination, organization, and success of over 15 different research studies. She has experience with a variety of clinical indications, including Major Depressive Disorder, treatment-resistant Major Depression, ADHD, Social Anxiety Disorder, Opioid Addiction, Mild Cognitive Impairment, Low Back Pain, and Osteoarthritis. She has worked in Phase II, III, and IV studies involving compounds administered orally, intravenously, and topically. Melissa is trained and certified in GCP, IATA, and CPR.
Melissa holds a Bachelor of Science in Health and Exercise Science from Wake Forest University. Prior to joining MRN, she worked on a retrospective neonatology research study at New York University Langone Medical Center. While completing her degree, Melissa conducted research on lifestyle interventions for diabetic patients, as well as exercise for pain reduction among patients with fibromyalgia.
Contact Melissa by email at: MMoran@MedicalResearchNetwork.com